Literature DB >> 20385717

Improving pharmacovigilance in Europe.

Nicholas Moore, Bernard Bégaud.   

Abstract

Mesh：

Year:  2010        PMID： 20385717     DOI： 10.1136/bmj.c1694

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  A cohort study exploring determinants of safety-related regulatory actions for biopharmaceuticals.

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Fakhredin A Sayed Tabatabaei; Huub Schellekens; Hubert G M Leufkens
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

3.  A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country.

Authors:  Jisha Myalil Lucca; Madhan Ramesh; Gurumurthy Parthasarathi; Dushad Ram
Journal:  Psychopharmacol Bull       Date:  2016-03-01

Review 4.  A plea for a more epidemiological and patient-oriented pharmacovigilance.

Authors:  Veronica Scurti; Marilena Romero; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2011-07-20       Impact factor: 2.953

Review 5.  Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.

Authors:  Jackie Inch; Margaret C Watson; Stella Anakwe-Umeh
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

6.  Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan.

Authors:  Michiko Yamamoto; Kiyoshi Kubota; Mitsuhiro Okazaki; Akira Dobashi; Masayuki Hashiguchi; Hirohisa Doi; Machi Suka; Mayumi Mochizuki
Journal:  Patient Prefer Adherence       Date:  2015-01-23       Impact factor: 2.711

7.  A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.

Authors:  Hisham Aljadhey; Mansour A Mahmoud; Thamir M Alshammari; Mohammed Al-Dhaeefi; Herve Le Louet; Susana Perez-Gutthann; Peter J Pitts
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.